You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nimotuzumab

Showing 26 - 50 of 69
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Tumors Trial in Beijing (radiation, drug, procedure)

Unknown status
  • Esophageal Neoplasms
  • IMRT simultaneous integrated boost
  • +4 more
  • Beijing, Beijing, China
    Zefen Xiao
Jul 25, 2019

Head Neck Cancer Trial in Singapore (Nimotuzumab, Cisplatin, Radiation)

Unknown status
  • Head and Neck Cancer
  • Nimotuzumab
  • +2 more
  • Singapore, Singapore
    National Cancer Center Singapore
May 1, 2019

Nasopharyngeal Carcinoma Trial in Guiyang (Nimotuzumab, Cisplatin)

Unknown status
  • Nasopharyngeal Carcinoma
  • Guiyang, Guizhou, China
    Cancer Hospital of Guizhou Medical University
Oct 31, 2018

Childhood Brain Stem Tumor Trial in Shanghai (Nimotuzumab, Temozolomide)

Unknown status
  • Childhood Brain Stem Neoplasm
  • Shanghai, Shanghai, China
    he Department of Radiation Oncology, Xin Hua Hospital Affiliated
Oct 14, 2018

Recurrent Nasopharyngeal Carcinoma Trial in Fuzhou (Nimotuzumab)

Unknown status
  • Recurrent Nasopharyngeal Carcinoma
  • Nimotuzumab
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Sep 10, 2018

Tumors, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma in Situ Trial in Guangzhou (Nimotuzumab,

Unknown status
  • Neoplasms
  • +7 more
  • Nimotuzumab
  • +3 more
  • Guangzhou, Guangdong, China
    Zhujiang Hospital
Aug 9, 2018

Advanced Cancer, ADCC, NK Cell Mediated Immunity Trial in Hangzhou (NK Cell adaptive transfer, Nimotuzumab)

Unknown status
  • Advanced Cancer
  • +4 more
  • NK Cell adaptive transfer
  • Nimotuzumab
  • Hangzhou, Zhejiang, China
    Hangzhou Cancer Hospital
Jun 12, 2018

Stomach Tumors Trial in Beijing (Irinotecan, nimotuzumab)

Unknown status
  • Stomach Neoplasms
  • Beijing, Beijing, China
    Peking cancer hospital
Jan 9, 2018

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, Korea, Republic of, Taiwan (Irinotecan, Nimotuzumab)

Terminated
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Kashiwa, Chiba, Japan
  • +36 more
Mar 23, 2018

Glioblastoma Trial in Guangzhou, Guangdong, Shenzhen (biological, drug, radiation)

Completed
  • Glioblastoma
  • Nimotuzumab
  • +2 more
  • Guangzhou, Guangdong, China
  • +4 more
Dec 24, 2017

Lung Cancer Trial in Guangzhou (Nimotuzumab, Gemcitabine, Carboplatin)

Unknown status
  • Lung Cancer
  • Nimotuzumab
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 9, 2017

Nasopharyngeal Carcinoma Trial in Hangzhou (Nimotuzumab, Radiation)

Unknown status
  • Nasopharyngeal Carcinoma
  • Nimotuzumab
  • Radiation
  • Hangzhou, Zhejiang, China
    Xiaozhong Chen
Jan 19, 2017

Cervical Cancer Trial in Xi'an (Cisplatin, External Beam Radiation Therapy, Internal Radiation Therapy)

Unknown status
  • Cervical Cancer
  • Xi'an, Shaanxi, China
    Department of Radiation Oncology, Xijing Hospital, Fourth Milita
Mar 9, 2016

Prosthesis Survival Trial in China (drug, radiation, other)

Unknown status
  • Prosthesis Survival
  • Nimotuzumab
  • +4 more
  • Beijing, Beijing, China
  • +13 more
Apr 19, 2016

Esophageal Squamous Cell Carcinomas Trial in China (Nimotuzumab, Paclitaxel, Cisplatin)

Unknown status
  • Esophageal Squamous Cell Carcinomas
  • Nimotuzumab
  • +3 more
  • Hefei, Anhui, China
  • +26 more
Jan 29, 2016

Pancreatic Cancer, Advanced or Metastatic Trial in Herne (Nimotuzumab)

Completed
  • Pancreatic Cancer, Advanced or Metastatic
  • Nimotuzumab
  • Herne, Germany
    Marienhospital Herne
Oct 13, 2015

NSCLC Trial in Beijing (nimotuzumab, Cisplatin, Etoposide)

Unknown status
  • Non-small Cell Lung Cancer
  • nimotuzumab
  • +3 more
  • Beijing, Beijing, China
    Cancer Institute & Hospital, Chinese Academy of Medical Sciences
Sep 11, 2015

Cervical Cancer Trial in Shanghai (Nimotuzumab, Carboplatin, Paclitaxel)

Unknown status
  • Cervical Cancer
  • Nimotuzumab
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai first people's hospital
Aug 17, 2015

Advanced Esophageal Trial in Shanghai (Nimotuzumab)

Completed
  • Advanced Esophageal
  • Nimotuzumab
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Aug 17, 2015

Solid Tumors Trial in Beijing (Nimotuzumab, irinotecan)

Unknown status
  • Solid Tumors
  • Beijing, Beijing, China
    Cancer Institute & Hospital, Chinese Academy of Medical Sciences
Aug 17, 2015

Nasopharyngeal Cancer Trial in China (Nimotuzumab, plus chemoradiotherapy)

Unknown status
  • Nasopharyngeal Cancer
  • Nimotuzumab
  • placebo plus chemoradiotherapy
  • Fuzhou, Fujian, China
  • +23 more
Oct 28, 2015

Squamous Cell Carcinoma Trial in China (Nimotuzumab, Placebo, cisplatin)

Unknown status
  • Squamous Cell Carcinoma
  • Nimotuzumab
  • +3 more
  • Beijing, Beijing, China
  • +16 more
Aug 19, 2015

Carcinoma, Head Neck Cancer Trial in Brazil (Radiation Therapy, Nimotuzumab, Cisplatin)

Withdrawn
  • Carcinoma
  • Head and Neck Cancer
  • Radiation Therapy
  • +2 more
  • Curitiba, Paraná, Brazil
  • +7 more
Jul 24, 2015

Pancreatic Cancer Trial in China (nimotuzumab, Gemcitabine, Placebo)

Unknown status
  • Pancreatic Cancer
  • nimotuzumab
  • +2 more
  • Bengbu, Anhui, China
  • +24 more
Jul 31, 2015

Breast Cancer Trial in China (Nimotuzumab, docetaxel, capecitabine)

Unknown status
  • Breast Cancer
  • Nimotuzumab
  • +2 more
  • Beijing, Beijing, China
  • +8 more
Jun 3, 2015